VNRX READ THE FULL VNRX RESEARCH REPORT RECENT EVENTS Nu.Q Discover to be Utilized in a Human Clinical Study On March 4, 2025 ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...

This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...

Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe, held in London from April 8th to 10th, aims to address common concerns among European Biomarker, Translational, and Clinical ...

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

Thomas Moehring highlights how advanced technologies such as mass spectrometry, automation and AI are accelerating biomarker ...

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...